RVNC vs. BIPC

Last updated Apr 1, 2026

Compare and contrast key facts about Revance Therapeutics, Inc. (RVNC) and Brookfield Infrastructure Corporation (BIPC).

Performance

RVNC vs. BIPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revance Therapeutics, Inc. (RVNC) and Brookfield Infrastructure Corporation (BIPC). The values are adjusted to include any dividend payments, if applicable.

RVNC vs. BIPC - Yearly Performance Comparison

	2026 (YTD)
RVNC Revance Therapeutics, Inc.	0.00%
BIPC Brookfield Infrastructure Corporation	-20.25%

Fundamentals

Total Revenue (TTM) RVNC : $247.00M BIPC : $3.68B
Gross Profit (TTM) RVNC : $174.52M BIPC : $2.34B
EBITDA (TTM) RVNC : -$150.16M BIPC : $3.24B

Returns By Period

RVNC

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

BIPC

• 1D: 3.10%
• 1M: -20.77%
• YTD: -12.15%
• 6M: -2.09%
• 1Y: 13.68%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

RVNC vs. BIPC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIPC

BIPC Risk / Return Rank: 56
BIPC Sharpe Ratio Rank: 60
BIPC Sortino Ratio Rank: 52
BIPC Omega Ratio Rank: 52
BIPC Calmar Ratio Rank: 55
BIPC Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RVNC vs. BIPC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Revance Therapeutics, Inc. (RVNC) and Brookfield Infrastructure Corporation (BIPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	RVNC	BIPC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.49	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.25	—

Dividends

RVNC vs. BIPC - Dividend Comparison

RVNC has not paid dividends to shareholders, while BIPC's dividend yield for the trailing twelve months is around 4.42%.

	TTM	2025
RVNC Revance Therapeutics, Inc.	0.00%	0.00%
BIPC Brookfield Infrastructure Corporation	4.42%	3.79%

Drawdowns

RVNC vs. BIPC - Drawdown Comparison

The maximum RVNC drawdown since its inception was 0.00%, smaller than the maximum BIPC drawdown of -25.28%. Use the drawdown chart below to compare losses from any high point for RVNC and BIPC.

Drawdown Indicators

	RVNC	BIPC	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-25.28%	+25.28%
Max Drawdown (1Y) Largest decline over 1 year	—	-25.28%	—
Current Drawdown Current decline from peak	0.00%	-21.80%	+21.80%
Average Drawdown Average peak-to-trough decline	0.00%	-6.10%	+6.10%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	6.41%	—

Volatility

Volatility by Period

	RVNC	BIPC	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	11.19%	—
Volatility (6M) Calculated over the trailing 6-month period	—	20.13%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	27.85%	-27.85%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	28.80%	-28.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	28.80%	-28.80%

Financials